Project description
A comprehensive strategy for accurate diagnosis of COVID-19 and other respiratory diseases
COVID-19, the infectious disease caused by the most recently discovered coronavirus, has spread to more than 200 countries worldwide. Detecting and differentiating Sars-CoV-2 from SARS-CoV, which emerged in November 2002, as well as 30 other common respiratory bacteria and viruses, is important. Failure to distinguish different pathogens may lead to unnecessary antimicrobial use, cross-infection of mis-grouped patients and further spreading of infectious disease. The EU-funded RAPID-COVID project will prototype a technique to simultaneously detect and differentiate SARS-CoV-2 and 30 other common respiratory bacteria and viruses. It will allow for accurate, cost-effective and comprehensive diagnoses during the current outbreak as well as for streamlined integration into future routine diagnoses of respiratory diseases.
Fields of science
Programme(s)
Topic(s)
Funding Scheme
IMI2-RIA - Research and Innovation actionCoordinator
OX14 3DB Abingdon
United Kingdom
Participants (4)
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.